VEGFA and colorectal cancer: In cases of inoperable metastases from colorectal cancer, a breakthrough that has increased the effectiveness of first- and second-line systemic chemotherapy is the inclusion of monoclonal antibodies (anti-EGRF or anti-VEGF) [10,11].